Sunil Healthcare share news, announcements and annual reports
NSE: SUNLOCBSE: 537253Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 30 Oct 2026. Previous close ₹61.00.
30 Oct: open ₹61.50, high ₹61.55, low ₹61.50
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹63 Cr3,191st largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 17.72
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 0.91
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 5.2%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 4.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.80
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 38100.0% delivered
Sunil Healthcare share news and announcements
463 announcements, routine notices left out, newest first. Page 8 of 10.
May 2017
3 May · Information Of Board Meeting To Be Held On 18.05.2017 In Pursuant To Regulation 29 Read With Regulation 33 & 47 Of The SEBI (Listing Obligation And Disclosure Requirement) Regulation, 2015
Apr 2017
11 Apr · Compliance Certificate Under Regulation 40 (9) & (10) Of The SEBI (Listing Obligation & Disclosure Requirement) Regulation, 2015
10 Apr · Submission Of Quarterly Statement Regarding Investor Complaint In Terms Of Regulation 13(3) Of The SEBI (Listing Obligation And Disclosure Requirement) Regulation, 2015 For The Quarter Ended 31.03.2017
10 Apr · Compliance Certificate As Per Regulation 7 (3) Of SEBI (Listing Obligation And Disclosure Requirement) Regulation, 2015 Fro The Half Year Ended 31.03.2017
8 Apr · Shareholding for the Period Ended March 31, 2017
Shareholding Pattern for the Period Ended March 31, 2017. For more details, kindly Click ....
Mar 2017
Feb 2017
14 Feb · Investor Release for December 31, 2016
13 Feb · Outcome of Independent Directors Meeting
Jan 2017
13 Jan · Shareholding for the Period Ended December 31, 2016
Shareholding Pattern for the Period Ended December 31, 2016. For more details, kindly Click ....12 Jan · Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended December 31, 2016
Nov 2016
12 Nov · Results
Oct 2016
10 Oct · Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended September 30, 2016
7 Oct · Shareholding for the Period Ended September 30, 2016
Shareholding Pattern for the Period Ended September 30, 2016. For more details, kindly Click ....
Sep 2016
3 Sep · Meeting
Register of Members & Share Transfer Books of the Company will remain closed from September 21, 2016 to September 28, 2016 (both days inclusive) ....
Aug 2016
12 Aug · Investor Release
Jul 2016
23 Jul · Board meeting
Meeting of the Board of Directors of the Company is scheduled to be held on Thursday, August 11, 2016 at 3.30 P.M. at Shri Ram Room, First Floor, ....14 Jul · Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended June 30, 2016
7 Jul · Shareholding for the Period Ended June 30, 2016
Shareholding Pattern for the Period Ended June 30, 2016. For more details, kindly Click ....
Jun 2016
15 Jun · Management
Mr. Rajat Kumar Niyogi, Director of the Company has resigned from the directorship of the Company with effect from June 15, 2016.
May 2016
30 May · Result Presentation for March 31, 2016
Apr 2016
10 Apr · Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended March 31, 2016
8 Apr · Shareholding for the Period Ended March 31, 2016
Shareholding Pattern for the Period Ended March 31, 2016. For more details, kindly Click ....
Mar 2016
16 Mar · Outcome of Independent Directors Meeting
Separate meeting of the independent directors of the Company held on March 15, 2016 and the following items were discussed in the meeting as under:- ....10 Mar · Demise of Director
Dr. Ranjit Bannerji, Independent Director of the Company died on March 05, 2016, therefore he ceased to hold office as director in the Company.